Cargando…
Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides
The p53 tumor suppressor serves as a major barrier against malignant transformation. Over 50% of tumors inactivate p53 by point mutations in its DNA binding domain. Most mutations destabilize p53 protein folding, causing its partial denaturation at physiological temperature. Thus a high proportion o...
Autores principales: | Tal, Perry, Eizenberger, Shay, Cohen, Elad, Goldfinger, Naomi, Pietrokovski, Shmuel, Oren, Moshe, Rotter, Varda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914250/ https://www.ncbi.nlm.nih.gov/pubmed/26943582 http://dx.doi.org/10.18632/oncotarget.7857 |
Ejemplares similares
-
Correction: Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides
por: Tal, Perry, et al.
Publicado: (2019) -
Targeting mutant p53 for cancer therapy
por: Oren, Moshe, et al.
Publicado: (2016) -
Mutant p53 Attenuates the Anti-Tumorigenic Activity of Fibroblasts-Secreted Interferon Beta
por: Madar, Shalom, et al.
Publicado: (2013) -
Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells
por: Sarig, Rachel, et al.
Publicado: (2010) -
Pseudo-mutant P53 is a unique phenotype of DNMT3A-mutated pre-leukemia
por: Tuval, Amos, et al.
Publicado: (2022)